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Effect of intraoperative infusion of sufentanil versus remifentanil on postoperative
shivering in Korea: a prospective, double-blinded, randomized control study
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Background/aim: The number of published papers that compare the incidence of sufentanil- and remifentanil-related postoperative
shivering is insufficient. We investigated the incidence of postoperative shivering after total intravenous anesthesia with either sufentanil
or remifentanil in patients who underwent elective surgery.
Materials and methods: Eighty-three patients, with a physical status classified as American Society of Anesthesiologists I or II, were
randomly allocated to either the remifentanil–propofol (RP group, n = 40) or sufentanil–propofol (SP group, n = 43) group. The primary
endpoint was the incidence of postoperative shivering 1 h after entering the recovery room. The secondary endpoints were intraoperative
core temperatures of the esophagus and tympanic membrane at 30 min after the induction of anesthesia and at the end of surgery.
Results: The overall postoperative shivering incidence was not significantly different between the RP (15%) and SP (11.6%) groups
(P = 0.651). The intraoperative temperatures and their changes (the temperature 30 min after induction minus that after surgery) as
measured at the distal esophagus and tympanic membrane were not significantly different between the RP and SP groups.
Conclusion: The incidence of postoperative shivering related to sufentanil was less than that related to remifentanil, with no significant
differences in the intraoperative core temperatures.
Key words: Postoperative period, remifentanil, shivering, sufentanil

1. Introduction
Postoperative shivering usually occurs as a type of
thermoregulatory response toward hypothermia, but
it also can develop as a result of postoperative muscle
hyperactivity, occurring even when the body temperature
is within normal limits (1). Postoperative shivering can
contribute to an increase in oxygen consumption (up
to 200% to 300%) and vascular resistance, resulting
from vasoconstriction (2,3). Fatal complications such as
myocardial infarction may eventually occur.
Because of their rapid onset and recovery profiles,
opioids are commonly used to control the intraoperative
hemodynamic changes, but they carry the risk of
postoperative shivering (4,5). Even though it is reported
that remifentanil is associated with an increased incidence
of postoperative shivering (ranging from 20% to 70%)
(4,6), there is still debate on whether remifentanil induces
more postoperative shivering compared to other opioids
(7–12). There are only a few reports on whether the
incidence of sufentanil-related postoperative shivering is
greater than that of remifentanil (4,6).

We hypothesized that the incidence of postoperative
shivering would be lower in patients who received
sufentanil rather than remifentanil. Therefore, we
investigated the incidence of postoperative shivering
after total intravenous anesthesia with either sufentanil or
remifentanil as a primary endpoint, and the intraoperative
core temperatures measured at the esophagus and
tympanic membrane as secondary endpoints.
2. Materials and methods
This prospective, randomized, controlled, double-blinded
study was approved by our Institutional Review Board and
registered with the Clinical Research Information Service
(CRIS, ref: KCT0001888). Written informed consent was
obtained from all participants, a legal surrogate, or the
parents or legal guardians of participants who were minors.
We enrolled 86 patients who were aged 20 to 65 years,
had an American Society of Anesthesiologists (ASA)
physical status classification of I or II, and were scheduled
to undergo elective surgery under total intravenous
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anesthesia. We excluded the patients who refused study
enrollment or had a neuromuscular disease, abnormal
hepatic, renal, or thyroid function, severe respiratory
suppression, brain lesions, or an allergy to the study drugs.
We excluded the patients who had taken medications
such as anticonvulsants, antidepressants, or opioids
within 2 weeks of the study. We also excluded pregnant
or breastfeeding women, or women who planned to get
pregnant.
All patients were randomly allocated to either the
remifentanil–propofol (RP group, n = 43) or sufentanil–
propofol (SP group, n = 43) group using a random numbers
table obtained via a computer program (Figure 1).
After premedication with intramuscular midazolam
(0.05 mg kg–1) 30 min prior to the induction of anesthesia,
the participant was transported to the operating room.
Prior to the induction of anesthesia, we recorded the
temperature of the tympanic membrane. The induction
and maintenance of anesthesia was performed with total
intravenous anesthesia using propofol (3 µg mL–1) and
either remifentanil (4.0 ng mL–1; RP group) or sufentanil
(0.5 ng mL–1; SP group) with a target-controlled infusion
(TCI) pump (Orchestra; Fresenius Vial, Brezins, France)
(13). After equilibration of the plasma and effect-site
target concentrations of all intravenous hypnotics and
opioids, we performed endotracheal intubation 1 min
after the injection of rocuronium bromide (0.6 mg kg–1)
and inserted an esophageal stethoscope at the best audible
site of heart sounds to record the esophageal temperatures.
The concentration of the propofol infusion was adjusted
to maintain the bispectral index score between 40 and
60. The concentrations of the remifentanil or sufentanil
infusions were adjusted in order to maintain mean arterial
pressure changes within ±20% during the maintenance of
anesthesia. The settings of mechanical ventilation were also
adjusted to maintain the ETCO2 between 35 to 45 mmHg
with a 50% oxygen–air mixture. Sustained hypotension
(≤80 mmHg of systolic arterial pressure) and bradycardia
(≤50 beat/min) were treated with intermittent bolus
injections of ephedrine (10 mg) and atropine (0.5 mg),
respectively. All patients were transferred to the recovery
room, which was automatically temperature-controlled at
28 ± 2 °C, after recovery from the neuromuscular block
with sugammadex (2 mg kg–1) at the end of surgery. Each
patient was routinely tucked under a blanket to maintain
body temperature during the stay in the recovery room.
The patients and investigators were blinded to the
study medications. A noninvestigating nurse loaded
them into indistinguishable numbered syringes and
randomized the medications using a random number
table. Noninvestigating anesthesiologists controlled
the concentration of the opioid infusions used for the
induction and maintenance of anesthesia.
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The primary endpoint was the incidence of
postoperative shivering, which was evaluated using a
table with a definition based on the degree of shivering
in 4 steps at 1 h after entering the recovery room (5). A
degree ≥1 was used as the cut-off value for significant
postoperative shivering. In the case of 2 or more points of
postoperative shivering, a forced-air warming device was
applied. The secondary endpoints were the intraoperative
core temperatures as measured at the esophagus (Teso) and
tympanic membrane (Ttym), which were recorded 30 min
after the induction of anesthesia and at the end of surgery.
In addition, we calculated and recorded the intraoperative
temperature changes (temperatures 30 min after induction
minus those after surgery) in the esophagus (Δ Teso) and
tympanic membrane (Δ Ttym). The demographic and
intraoperative data (sex, ASA physical status, age, height,
weight, operation type, operation time, anesthesia time,
urine output, blood loss, intravenous fluid intake, infusion
rate of remifentanil or sufentanil, and room temperature)
were also recorded. Urine output (UO) was categorized
into the 3 subgroups for analysis: 0 mL, 0 mL–500 mL, and
≥500 mL.
2.1. Statistical analysis
The necessary sample size was calculated by taking the
level of statistical significance as α = 0.05 and β = 0.2
using z-tests of G*Power software (v3.1.9.1) with different
proportions of the incidences of postoperative shivering
in the remifentanil (0.63) and alfentanil (0.325) groups,
which were reported in Apitzsch’s study (14). We required
42 patients in each group and enrolled 86 patients,
assuming that the dropout rate would be 5%.
SPSS (Windows v21.0, IBM Corp., Armonk, NY, USA)
was used for statistical analysis. All measured values are
presented as either the mean ± SD, mean (95% confidence
intervals [95% CI]), or number of patients (%).
The data on the incidence of postoperative shivering,
sex, ASA physical status, operation type, and category of
urine output were compared using the chi-square test. The
data on age, height, operation time, anesthesia time, blood
loss, intravenous fluid intake, and room temperatures were
compared using Student’s t-test. The data on intraoperative
temperatures of the esophagus and tympanic membrane
and their intraoperative changes were also compared
using Student’s t-test. P < 0.05 was considered to indicate
statistical significance.
3. Results
Eighty-three patients were enrolled, because 3 patients
in the RP group were excluded due to the cancellation
of their surgery (2 patients) and an allocation failure (1
patient) (Figure 1).
There were no significant differences in the age, sex,
height, weight, operation type, and ASA physical status
between the RP and SP groups (Table 1).
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Figure 1. CONSORT Flow chart.

The postoperative shivering incidence was not
significantly different between the RP and SP groups
(Table 2, P = 0.694). The overall postoperative shivering
incidence was not significantly different between the RP
(15%) and SP groups (11.6%, P = 0.651; Table 2).
The intraoperative baseline tympanic membrane
temperatures were not significantly different between the
RP and SP groups (36.1 [36.0–36.2] °C vs. 36.2 [36.1–36.3]
°C, respectively; P = 0.687) (Figure 2). The intraoperative
tympanic membrane temperatures at the end of surgery
were not significantly different between the RP and SP

groups (35.8 °C [35.6–36 °C] vs. 35.7 °C [35.5–35.9
°C], respectively; P = 0.735) (Figure 2). Similarly, the
intraoperative tympanic membrane temperature change
(the temperature 30 min after induction minus that after
surgery; ΔTtym) was not significantly different between
the RP and SP groups (0.3 [0.2–0.4] °C vs. 0.4 [0.3–0.5] °C,
respectively; P = 0.354) (Figure 2).
The intraoperative baseline distal esophageal
temperatures were not significantly different between the
RP and SP groups (35.9 [35.7–36.1] °C vs. 36.1 [35.9–36.3]
°C, respectively; P = 0.234) (Figure 2). The intraoperative
distal esophageal temperatures at the end of surgery were
not significantly different between the RP and SP groups
(35.6 [35.4–35.8] °C vs. 35.6 [35.4–35.8] °C, respectively;
P = 0.692] (Figure 2). There was also no difference in the
change in intraoperative distal esophagus temperature
(ΔTeso) between the RP and SP groups (0.4 [0.3–0.5] °C
vs. 0.4 [0.3–0.5] °C, respectively; P = 0.394) (Figure 2).
There were no significant differences in the
intraoperative data including operation time, anesthesia
time, urine output, blood loss, intravenous fluid intake,
and room temperature between the RP and SP groups
(Table 3).
4. Discussion
In the present study, the overall incidence of postoperative
shivering in patients who received sufentanil (11.6%) was
lower than that in patients who received remifentanil

Table 1. Patient characteristics.
RP group (n = 40)

SP group (n = 43)

P value

Sex (M/F)

20/20

24/19

0.596

ASA physical status (I/II)

30/10

24/19

0.067

Age (years)

45.6 ± 11.6

47.4 ± 12.4

0.493

Height (cm)

166.1 ± 8.2

166.6 ± 8.1

0.758

Weight (kg)

68.4 ± 13

68.4 ± 10

0.986

General surgery

7 (17.5)

5 (11.6)

Gynecological surgery

1 (2.5)

2 (4.7)

Oral and maxillofacial surgery

3 (7.5)

1 (2.3)

Orthopedic surgery

11 (27.5)

6 (14.0)

Otolaryngological surgery

6 (15.0)

10 (23.3)

Plastic surgery

1 (2.5)

1 (2.3)

Spine surgery

8 (20.0)

13 (30.2)

Urologic surgery

3 (7.5)

5 (11.6)

Operation type

0.572

The values are expressed as mean ± SD or numbers of patients (n [%]). There are no significant differences between
groups. ASA: American Society of Anesthesiologists. P < 0.05 was considered to indicate statistical significance.
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Figure 2. Intraoperative temperatures of distal esophagus and tympanic membrane (°C). There were
no significant differences between the groups. Ttym: tympanic membrane temperature; Teso: distal
esophageal temperature; Δ Temperature: temperature change (the temperature 30 min after induction
minus that after surgery); Δ Ttym: tympanic membrane temperature change; Δ Teso: intraoperative
distal esophagus temperature change; before: before induction; baseline: 30 min after induction; end:
end of surgery. The values are expressed as mean (95% confidence intervals). P < 0.05 was considered
to indicate statistical significance.
Table 2. Incidence and grade of postoperative shivering.

Overall incidence of postoperative shivering

RP group (n = 40)

SP group (n = 43)

P value

6 (15)

5 (11.6)

0.651

Grade of postoperative shivering

0.694

0: No shivering

34 (85)

38 (88.4)

1: Mild fasciculation of face or neck

2 (5)

2 (4.7)

2: Visible tremor involving more than one muscular group

3 (7.5)

1 (2.3)

3: Gross muscular activity involving the entire body

1 (2.5)

2 (4.7)

The values are expressed as numbers of patients (n [%]). There were no significant differences between the groups. P < 0.05 was
considered to indicate statistical significance.

(15%), with no significant difference in the intraoperative
core temperatures. A meta-analysis showed that the
incidence of postoperative shivering associated with
remifentanil was similar to that of sufentanil, but higher
than that of fentanyl and alfentanil (4,6).
Postoperative shivering incidence of remifentanil has
been reported to increase according to increase in infusion
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rate. Postoperative shivering was significantly greater in
patients who received high doses (0.25–0.3 µg kg–1 min–1)
of remifentanil than in those who received low doses (0.1
µg kg–1 min–1) (5,15). Nakasuji et al. (15) also reported
that high doses of remifentanil induced a higher incidence
(60%) of postoperative shivering compared with low doses
(20%). In our study, the mean infusion rate of remifentanil
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Table 3. Intraoperative data.
RP group (n = 40)
IR of remifentanil (µg kg–1 min–1)

SP group (n = 43)

P value

0.13 (0.11–0.15)

IR of sufentanil (ng kg–1 min–1)

8.8 (8.1–9.5)

Operation time (min)

142.1 (110.7–173.5)

129 (108.5–149.4)

Anesthesia time (min)

163.5 (131.2–195.8)

153.6 (132.7–174.5)

Urine output [UO; n (%)]

0.480
0.605
0.057

0 mL = UO

21 (52.5)

29 (67.4)

0 mL < UO < 500 mL

12 (30)

13 (30.2)

500 mL ≤ UO

7 (17.5)

1 (2.3)

Blood loss (mL)

165.8 (53.1–278.4)

153.6 (59.1–128.1)

Intravenous fluid intake (L)

1.1 (0.7–1.4)

0.9 (0.7–1.0)

0.392

Troom, baseline (°C)

21.5 (21.1–21.8)

21.3 (21–21.6)

0.495

Troom, end (°C)

21.7 (31.3–22)

21.5 (21.2–21.9)

0.496

0.222

The values are expressed as mean (95% confidence intervals) or numbers of patients (n [%]). There were no significant
differences between the groups. Baseline: at 30 min after induction; End: the end of surgery. IR: infusion rate. P < 0.05 was
considered to indicate statistical significance.

was 0.13 µg kg–1 min–1, which was defined as a low dose
(5,15). Our study showed an overall 15% postoperative
shivering incidence after infusion of remifentanil, which
was similar to the results of Nakasuji’s study (15).
Sufentanil linearly decreased the shivering threshold as
the infusion rate increased (16). However, the incidence of
postoperative shivering after the infusion of sufentanil had
not been sufficiently evaluated. A meta-analysis reports
that the postoperative shivering incidence of sufentanil
was about 4.1% (4). Martorano et al. (11) reported that
the incidence of postoperative shivering was 6.3% after the
infusion of sufentanil at a rate of 5–40 ng kg–1 min–1. In our
study, the mean infusion rate of sufentanil was 8.8 ng kg–1
min–1, and the overall incidence of postoperative shivering
related to sufentanil was 11.6%.
Even though opioids have a less potent effect on
thermoregulatory control than volatile or intravenous
anesthetics, opioids impair thermoregulation via reduction
in the threshold for vasoconstriction and shivering. There
is an unchanged gain and maximum intensity of shivering

with a linear function of plasma opioid concentration (17–
19). Therefore, shivering might not occur during opioid
administration because opioids, or other anesthetics
administered simultaneously, suppress shivering (20).
However, opioids may be the only drugs remaining that
blunt the thermoregulatory reflexes in patients who
are hypothermic postoperatively because the volatile
anesthetics are quickly exhaled after anesthesia (17).
Postoperative shivering normally occurs when patients
develop intraoperative hypothermia due to an impairment
of central and peripheral thermoregulation by anesthesia
(17). In our study, either remifentanil or sufentanil
infusion led to the development of mild intraoperative
hypothermia (above 35 °C) with nonsignificant differences
at the end of surgery. This implies that both remifentanil
and sufentanil equally influence the impairment of
thermoregulation intraoperatively, and similar incidence
of postoperative shivering may thus be expected as a
consequence. In our study, remifentanil caused a higher
incidence of postoperative shivering than sufentanil;
however, this difference was not significant.
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Even though we used the mean (95% CI) infusion
rates of remifentanil (0.13 [0.11–0.15] µg kg–1 min–1) and
sufentanil (8.8 [8.1–9.5] ng kg–1 min–1) (Table 3), as the
potency of sufentanil is ten times that of remifentanil,
these rates were close to being equivalent (21). There are
several reasons why remifentanil may have caused an
insignificantly higher incidence of postoperative shivering
than the other opioids. We focus here on the complex
thermoregulatory mechanisms via the NMDA receptor
and opioid receptor, which may account for the occurrence
of shivering (20).
First, the opioid’s effect on the µ receptor plays a role
in the inhibition of postoperative shivering by increasing
the interthreshold range (22). The threshold temperature
for postoperative shivering has a linear relationship with
the plasma concentration of opioids, but the plasma
concentration that allows for spontaneous breathing does
not seem as potent as with other antishivering drugs, such
as meperidine (22). Postoperative shivering might be a
result of the sudden decrease in the suppression of shivering
by the opioids due to a weak or vanishing interaction
between the opioid and µ receptor (20). When compared
to other opioids, remifentanil in particular is more rapidly
metabolized by plasma esterase and cleared from the blood
within minutes after stopping the infusion. Therefore,
the abrupt withdrawal of remifentanil without providing
effective analgesic may aggravate the postoperative pain
in patients. This can cause postoperative shivering by
nonthermoregulatory rhythmic muscular activity earlier
and more intensely than with sufentanil, even when patients
are normothermic and vasodilated (1,8,9,17,23,24). Sessler
(17) also suggested that remifentanil does not have a
residual opioid effect to blunt thermoregulatory responses
to hypothermia; thus, the high incidence of shivering in
patients who have received intraoperative remifentanil is
not surprising compared to that of those who received the
longer-acting opioids.
The second reason is the activation of the central
glutamatergic system, such as N-methyl-d-aspartate
(NMDA) receptors, by the opioids. Short-acting opioids
such as remifentanil may cause an acute opioid tolerance

and opioid-induced hyperalgesia, which is significantly
correlated with an increased risk of postoperative
shivering by increasing pain (5,17,25). This mechanism’s
significance can be supported by the results of some
investigators who showed that the postoperative shivering
associated with remifentanil was attenuated by the
inhibition of the NMDA receptor using ketamine and
tramadol (5,15,20). Interestingly, the NMDA receptor can
be activated by glycine, which acts as an acidic buffer in
the drug preparation of remifentanil (26,27). Kleckner and
Dingledine (27) reported that intraoperative high-dose
remifentanil has enough high-dose glycine to activate
NMDA receptors, while low-dose remifentanil does not.
Therefore, in our study, which used low-dose remifentanil,
the incidence of postoperative shivering related to
remifentanil was lower than that of studies by other
investigators who used high-dose remifentanil (5,15). The
effect of glycine does not explain postoperative shivering
caused by other opioids, because glycine is not found in
their preparation.
There are some limitations associated with the present
study. First, to evaluate hypothermia in the patients,
we used the tympanic membrane and distal esophageal
temperatures at the end of surgery, instead of the
postoperative core temperature during recovery. Second,
we could not confirm that postoperative shivering is related
to postoperative pain, opioid-induced hyperalgesia, or
acute opioid tolerance, because we did not evaluate them
during recovery.
In conclusion, sufentanil induced less postoperative
shivering than remifentanil, even though equivalent
doses of the opioids were infused, and the same degree of
mild intraoperative hypothermia developed. In addition,
we need to pay attention to complex thermoregulatory
mechanisms via the NMDA receptor and opioid receptor,
which may account for the occurrence of shivering.
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